According to Nova one advisor, the global PRP and PRF in Cosmetics market size is expected to hit around USD 613 million by 2030 from valued at USD 190 million in 2021 and growing at a CAGR of 13.6% from 2022 to 2030.
Rise in number of cosmetic surgical procedures, surge in awareness about PRP and PRF therapies, and increase in applications of PRP & PRF in cosmetics are propelling the global market. Developed economies such as the U.S. and countries in Europe accounted for substantial share of the global PRP and PRF in cosmetics market in 2021. However, high cost of products and possibility of complications in cosmetic surgeries are expected to restrain the global PRP and PRF in cosmetics market. Nevertheless, the platelet-rich plasma (PRP) treatment shows improvement in volume, tone, and texture of the skin. It also reduces the appearance of wrinkles. Hence, PRP therapy is becoming quite popular in skin treatment. Thus, demand for PRP and PRF in cosmetics is likely to increase during the forecast period.
Over the last few years, small and large biopharmaceutical companies have become increasingly reliant on contract research organizations (CROs) and other clinical service specialists to provide research services for their R&D operations. Changing lifestyles of the people in developing regions, increase in per capita income, and rise in awareness about beautification contribute to the growth of the global PRP and PRF in cosmetics market. Outsourcing of stem cell trials is also expected to drive the market by the end of the forecast period.
Report Scope of the PRP and PRF in Cosmetics Market
Report Coverage |
Details |
Market Size |
USD 613 million by 2030 |
Growth Rate |
CAGR of 13.6% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Type, Origin, Cosmetic Application and Region, |
Companies Mentioned |
|
Surge in Awareness about Benefits of PRP Therapy to Drive Global Market
PRP was first used in cardiac surgery in 1987. Awareness about the advantages and applications of PRP was limited to research laboratories. Currently, value-added advantages and applications of PRP therapy over conventional wound healing & disease treatments, such as surgery and medicines, have resulted in higher demand for PRP products globally. This is offsetting the limitations of PRP and PRF in cosmetics.
PRP therapy is used in cosmetics to reduce wrinkles, plump up the sagging skin, get rid of deep creases, improve complexion, and diminish acne scars. The middle-aged and elderly population is increasingly opting for plastic surgeries to look esthetically appealing and young. Thus, rise in awareness about these surgeries among the population is projected to boost the market during the forecast period.
Increase in awareness has also been driving the demand for platelet rich plasma therapy since the last few years in emerging economies such as China, India, Brazil, and Russia as well as in developed regions including North America and Europe. Global players such as Cesca, Harvest, Arthrex, and Biomet are strengthening their existing distribution networks in these regions in order to increase their market presence.
Rise in Number of Facial Cosmetic Surgeries Boosting Demand for PRP Therapy
PRP and PRF exhibit high potential in cosmetic treatments. PRP therapy can be used as a dermal filler for rapid healing of injuries. It is an effective substitute for hyaluronic acid. According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 10,129,529 cosmetic surgeries were performed in 2020 across the world, which included 1,601,713 breast augmentation procedures, 968,381 eyelid surgeries, and 1,300,020 liposuction procedures. As per the American Society of Plastic Surgeons (ASPS), about 1,811,754 cosmetic surgical procedures were performed in the U.S. in 2020. Thus, increase in the number of cosmetic surgeries is likely to drive the demand for PRP and PRF in cosmetics during the forecast period.
According to the American Society of Plastic Surgeons (ASPS), plastic surgery gained popularity in 2020, with around 18.1 million cosmetic procedures performed in the same year, along with 16.23 million cosmetic minimally-invasive procedures. Adoption of platelet rich plasma therapy is increasing due to its effectiveness in facial therapy, rhytides treatment, oral-maxillofacial surgery, and augmentation of soft tissue repair. This is likely to propel the market during the forecast period.
Pure-PRP Holds Promising Potential for Skin Treatments
The pure-PRP segment is projected to account for around 61% share of the global market in 2021. The trend is projected to continue during the forecast period. Pure PRP has platelet and growth factor concentrations, which promote skin rejuvenation. Hence, the demand for pure PRP is increasing.
Technological advancements leading to the use of pure PRP in various applications and rich platelet content are expected to drive the segment in the next few years. Furthermore, ease of production and cost-effectiveness are expected to propel the segment in the near future. Applications of leukocyte-rich PRP include enhancement of wound healing, bone regeneration, and repair of the soft tissue. Distinct advantages of pure PRF over pure PRP & L-PRP and continuous innovation to improve the effectiveness of PRF are the key factors anticipated to fuel the pure-PRF segment during the forecast period.
Autologous Products Gain Prominence in Skin Healing Applications
The autologous segment is driven by the cost-effectiveness of autologous PRP and PRF. Platelet rich plasma (PRP) has been proven to be a prominent source of autologous products in the field of regenerative medicine and a true precursor for the healing process along with scaffold & stem cells.
Growing Need for Skin Rejuvenation Treatment Propels Demand for PRP Therapies
Demand for PRP and PRF cosmetic treatments such as that in skin rejuvenation is largely driven by the increase in number of cosmetic surgeries, presence of a well-established health care infrastructure, and rise in applications of PRP therapies in cosmetic surgeries for facial therapy. Growth in need for skin rejuvenation treatment is augmenting the demand for PRP therapies across the globe.
Regional Outlook of Global PRP and PRF in Cosmetics Market
North America constituted the major share of more than 38% of the global market in 2021. The trend is expected to continue during the forecast period due to new product approvals, technological advancements, and increase in applications of PRP in cosmetic surgeries in the region. Increase in investments by governments in the health care sector and innovations in PRP & PRF in cosmetics are projected to augment the market in North America during the forecast period.
The U.S. dominated the market in North America, with more than 87% share in 2021. The trend is projected to continue during the forecast period. Rise in awareness about PRP devices along with the launch of FDA-approved devices is anticipated to propel the market in the U.S. during the forecast period.
Europe held the second-largest share of the global market in 2021. Demand for PRP & PRF in cosmetics in Europe is fueled by cosmetic interventions and rise in esthetic surgeries in the region. Well-established health care infrastructure, rise in adoption of platelet-rich plasma for hair therapy, surge in the number of general as well as cosmetic surgeries, and usage of injectable PRF for facial rejuvenation are expected to augment the market in Europe.
Some of the prominent players in the PRP and PRF in Cosmetics Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global PRP and PRF in Cosmetics market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders